|
Market Closed -
Oslo Bors
18:45:00 02/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 42.30 NOK | +0.24% |
|
-3.42% | -8.24% |
| 09-23 | DNB Carnegie raises OMDA price target to 66 Norwegian kroner (61), reiterates buy | FW |
| 09-23 | Omda Completes Rollout of Oncology Medication Software in Norway | MT |
Company Valuation: Omda
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 1,803 | 796.8 | 755.7 | 665 | 945.4 | 867.5 | - | - |
| Change | - | -55.81% | -5.16% | -11.99% | 42.16% | -8.24% | - | - |
| Enterprise Value (EV) 1 | 2,014 | 1,095 | 1,112 | 1,026 | 1,350 | 1,273 | 1,193 | 1,085 |
| Change | - | -45.64% | 1.58% | -7.7% | 31.58% | -5.7% | -6.28% | -9.05% |
| P/E | -20.2x | -6.05x | 7.43x | -11.7x | 149x | -41.5x | 16.3x | 11.5x |
| PBR | 10.8x | 27.7x | 8.14x | 40.6x | 59x | 264x | 15.4x | 6.58x |
| PEG | - | -0.1x | -0x | 0x | -1x | 0x | -0x | 0.3x |
| Capitalization / Revenue | 5.45x | 2.16x | 1.82x | 1.55x | 1.91x | 1.72x | 1.31x | 1.25x |
| EV / Revenue | 6.09x | 2.96x | 2.68x | 2.39x | 2.72x | 2.52x | 1.81x | 1.57x |
| EV / EBITDA | 48.1x | 474x | 17.6x | 19.4x | 11.6x | 9.1x | 6.38x | 4.96x |
| EV / EBIT | -50.9x | -12.1x | 8.64x | -327x | 26.9x | 17x | 10.3x | 7.43x |
| EV / FCF | -736x | -21.6x | -412x | 15.9x | 41.3x | 37.5x | 10.6x | 9.96x |
| FCF Yield | -0.14% | -4.62% | -0.24% | 6.28% | 2.42% | 2.67% | 9.47% | 10% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -4.251 | -6.276 | 4.977 | -2.828 | 0.3099 | -1.02 | 2.59 | 3.68 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 330.7 | 369.7 | 415.1 | 429 | 495.7 | 505 | 660 | 693 |
| EBITDA 1 | 41.83 | 2.307 | 63.26 | 52.94 | 116.7 | 140 | 187 | 219 |
| EBIT 1 | -39.54 | -90.45 | 128.7 | -3.137 | 50.18 | 75 | 116 | 146 |
| Net income 1 | -89.12 | -131.6 | 104.4 | -59.29 | 6.608 | -22 | 55 | 78 |
| Net Debt 1 | 210.5 | 297.9 | 356.3 | 361.3 | 405.1 | 406 | 326 | 218 |
| Reference price 2 | 86.00 | 38.00 | 37.00 | 33.00 | 46.10 | 42.30 | 42.30 | 42.30 |
| Nbr of stocks (in thousands) | 20,967 | 20,967 | 20,423 | 20,153 | 20,508 | 20,508 | - | - |
| Announcement Date | 25/02/22 | 28/02/23 | 01/03/24 | 26/02/25 | 02/03/26 | - | - | - |
1NOK in Million2NOK
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -41.47x | 2.52x | 9.1x | - | 90.12M | |
| 32.54x | 5.7x | 21.86x | 0.28% | 242B | |
| 36.27x | 6.5x | 20.6x | 0.66% | 150B | |
| 42.48x | 11.22x | 24.76x | -.--% | 138B | |
| 16.11x | 3.32x | 10.81x | -.--% | 61.74B | |
| 33.65x | 6.72x | 21.27x | -.--% | 49.08B | |
| 18.6x | 2.27x | 11.53x | 2.71% | 47.43B | |
| 32.68x | 6.47x | 21.96x | 0.62% | 47.3B | |
| 41.85x | 10.08x | 22.22x | -.--% | 44.25B | |
| 74.44x | 7.11x | 21.64x | -.--% | 41.78B | |
| Average | 28.71x | 6.19x | 18.57x | 0.47% | 82.27B | |
| Weighted average by Cap. | 35.55x | 6.81x | 20.67x | 0.39% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- CSAM Stock
- Valuation Omda
Select your edition
All financial news and data tailored to specific country editions
